Keywords: Myocardium, Cardiomyopathy
Motivation: To identify who may benefit from implantable cardioverter-defibrillator (ICD) in end-stage dilated cardiomyopathy (DCM).
Goal(s): To explore the predictive value of a newly cardiac magnetic resonance (CMR) geometry parameter, LV remodeling index (LVRI), for ventricular tachyarrhythmia (VTA) in DCM patients with LVEF <35%.
Approach: Consecutive DCM patients with LVEF <35% (n=271) were followed up for VTA, including sudden cardiac death or major ventricular arrhythmias. Competing risk regression analysis was used to evaluate the association of LVRI with VTA.
Results: LVRI ≥7.5 is independently associated with lethal VTA in DCM patients with LVEF <35%.
Impact: CMR-derived LVRI is associated with VTA in patients with nonischemic DCM with LVEF <35%, which may have clinical significance in guiding future implantable cardioverter-defibrillator implantation and improving risk stratification for DCM patients with LVEF <35%.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords